 LAWRENCEVILLE, N.J., Feb. 26, 2021 GLOBE NEWSWIRE -- Celsion Corporation NASDAQ: CLSN, a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that management will be holding one-on-one meetings with investors during the Virtual 33rd Annual Roth Conference, being held March 15 17, 2021. A webcast of Celsions presentation will be pre-recorded and will be available on the Companys website during the week before the conference. 